Objective-The distribution and production of basic fibroblast growth factor (bFGF) was examined on the synovium from patients with rheumatoid arthritis
determined by an immunohistochemical staining procedure using anti-bFGF monoclonal antibody. The expression of bFGF mRNA was detected by nonradioactive in situ hybridisation using bFGF antisense oligo DNA. Results-The bFGF was found in the synovial lining cell, sublining stromal fibroblast-like cells, and vascular endothelial cells from patients with RA and OA. Little or no bFGF was found in noninflamed synovium. Immunostaminig of bFGF in the synovial cells was more extensive and intense in synovium of patients with RA than that ofpatients with OA. The nuclei of the synovial lining cell layer were also immunostained. These nuclear staining were more intense in the lining cell layer from RA patients with moderate or severe proliferation of synovial cells than in RA patients with mild proliferation. The bFGF mRNA was also detected in the synovial lining cell layer of the inflamed synovium. Rheumatoid arthritis (RA) is a disease of joints with polyarticular inflammation, destruction of bones and cartilage, and ankylosis. The inflamed synovium of RA is characterised by pronounced hyperplasia of the synovium, angiogenesis and inflammatory cell infiltration in the synovium. Transforming growth factor-I (TGF-P),' 2 platelet-derived growth factor (PDGF)3-5 and acidic as well as basic fibroblast growth factor (FGF) have been shown to regulate the proliferation of human synovial fibroblasts.' 6 7 Moreover, some of these growth factors have turned out to be the actual products of synovial cells themselves; PDGF protein as well as mRNA is detected in the synovial cells from patients with RA. 3 Basic FGF (bFGF) is a 146 amino acid protein with molecular weight of 18 000 and believed to be an autocrine and/or paracrine growth and angiogenesis factor, and is released extracellulary. The factor lacks the signal peptide sequence for secretion. 8 The pathway of bFGF secretion has been the focus of studies, but has not been clarified.9 10 The role of bFGF (and acidic FGF) for synovial proliferation has been studied in vivo and in vitro. The supernatant of cultured synovial cells contained mitogenic activity, and the biological properties were identical to bFGF.6 Furthermore, the synoviocytes express bFGF mRNA. These results suggest that synoviocytes themselves produce bFGF. 6 Our previous study also indicated that the supernatant of mechanically-wounded endothelial cells and synovial cells (by scraping from the substratum) had the proliferative activity of endothelial cells or synovial cells themselves, and it was regarded as bFGF based upon evidence that the factor binds to heparinsepharose column, and is eluted by washing with 2-0 M NaCl. Furthermore, protein sulphate (which blocks the interaction of FGFs and their receptors) and anti-bFGF antibody inhibited the mitogenic activity of the supernatant. l ' To investigate what type of cells in the synovium produce bFGF in patients with RA and OA, the expression of bFGF protein and mRNA was examined by means of immunohistochemistry and in situ hybridisation, respectively. Finally, we studied the relationship between the expression of bFGF and the disease activity of patients with RA.
Conclusion

Materials and methods
PREPARATION OF SYNOVIAL TISSUES
Specimens of inflamed synovium were obtained from patients who were undergoing total knee joint replacement or synovectomy. Fifteen tissues were from patients with RA who met the American Rheumatology Association 1987 revised criteria for the classification of RA,12 and five were from patients with OA.
Five normal synovial tissues were also obtained from patients who were having corrective surgery with joint trauma. The patients are Table 2 The oligodeoxy nucleotide DNA probe sequence ofhuman basic FGF usedfor this study 1 20 bFGF sequence :5'
---CGCAGGGACC-ATG-GCA-GCC-GGG-AGC-ATC-ACC-ACG-CTG-CCCAntisense probe : 3' TTA-TTA-TTA-C-CGT-CGG-CCC-TCG-TAG-TGG-TGC-GAC-GGG-
-GCC-TTG-CCC-GAG-GAT-GGC-GGC-AGC-GGC-GCC---3'
-CGG-AAC-GGG-CTC-CTA-CC-Al--ATT Although no significant difference was detected between the active and inactive group with RA in the incidence and intensity of bFGF expression, bFGF expression might be involved in the local inflammation and proliferation in each joints with RA. To examine this possibility, tissues from RA were divided into three grades, according to the local inflammatory grades evaluated by an arthroscopic examination, and the correlation of bFGF expression and local inflammation activity was investigated. As summarised in table 5, the nuclear staining of bFGF in the synovial lining cells and the cytoplasmic staining in the vascular endothelial cells in the grade 2 and grade 3 tissues was more intense than that in grade 1 tissues. In contrast to the nuclear staining, the cytoplasm of synovial lining cells of the grade 1 tissues had more intense staining than that of the grade 2 and grade 3 tissues. Various lines of evidence have strongly suggested the involvement of nuclear localisation of bFGF in cell proliferation; proliferating adult bovine aortic endothelial cells has already shown nuclear and nucleolar localisation of bFGF,'5 the nuclei of the quiescent confluent endothelial cells are void of bFGF, and two hours after the addition of bFGF, bFGF is preferentially accumulated in the nuclei accompanying the transition of the cells from the Go to GI phase of the cell cycle. '9 The nuclear bFGF may be involved in the regulation of cell proliferation through a direct interaction with DNA or through activation of nuclear protein kinases.5 20 21 In addition, a nuclear translocation was essential for aFGF to stimulate cell proliferation since the mutant aFGF, which lacks the sequence for nuclear translocation, cannot stimulate DNA synthesis and mitosis.22 Together with the above findings, the present results indicated that the nuclear expression of bFGF is associated with a degree of proliferation rather than being a disease specific mechanism.
It has been shown that basement membranes and extracellular matrix (ECM) bind bFGF through heparan sulphate and heparin-like molecules and act as storage sites for bFGF.8 23-25 Heparin or heparin-like substitute prevents bFGF from proteolytic degradation.26 Furthermore, Yayon et al reported in their study that the binding to heparan sulphate is required for binding to the high affinity bFGF receptor.27 It seems that when cells are injured, the stored bFGF is free from the ECM either by the degradation of ECM by proteolytic enzymes released from the injured cells or competitively replaced by incoming heparin from ECM."1 In the present study, bFGF was not detectable along the basement membranes of synovial lining cells and vascular endothelial cells which contained bFGF. Considering that RA and OA are characterised by the active proliferation of synovial lining cells, these results may support the idea that bFGF synthesised in these cells is utilised by themselves as an autocrine growth factor. 28 29 To support this, further studies are required.
